CLINICAL_TRIALS
trial_result
· 2022-09-07
Clinical Trial Update: Quinagolide Vaginal Ring on Lesion Reduction Assessed by MRI in Women With Endometriosis/Adenomyosis [Phase 2]
Summary
Phase 2 clinical trial update on a quinagolide vaginal ring for endometriosis/adenomyosis assessing lesion reduction by MRI.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ferring Pharmaceuticals | Conditions: Endometriosis | Phase 2 | Status: COMPLETED | Results posted: 2022-09-07